<?xml version="1.0" encoding="UTF-8"?>
<list>
  <sentences>
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1472-684X-1-5.anc" start="12762" end="12766" sStart="-1" offset="0" sid="null" wn="2147483645" wnkey="null" text="NSAIDs &lt;b&gt;work&lt;/b&gt;, at least in part, by inhibiting cyclo-oxygenase, the enzyme that converts arachidonic acid to prostaglandins." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-684X-1-5.anc" start="27390" end="27393" sStart="null" offset="48" sid="r8.way.n.0611" wn="2" wnkey="way%1:04:01::" text="Believing the patient's self report is the best way to assess it." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-684X-1-5.anc" start="16384" end="16388" sStart="null" offset="112" sid="r10.wait.v.0838" wn="2" wnkey="wait%2:42:01::" text="In fact, if pain is severe and uncontrolled after 1 or 2 doses (eg, crescendo pain), do not wait for 24 hours to pass before increasing the routine dose." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-684X-1-5.anc" start="37096" end="37100" sStart="null" offset="133" sid="null" wn="1" wnkey="use%2:34:01::" text="Detergent laxatives (eg, docusate) at conventional doses are only stool softeners, and are rarely effective when used alone for patients at the end-of-life." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-684X-1-5.anc" start="37096" end="37100" sStart="null" offset="133" sid="null" wn="1" wnkey="use%2:34:01::" text="Detergent laxatives (eg, docusate) at conventional doses are only stool softeners, and are rarely effective when used alone for patients at the end-of-life." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-684X-1-5.anc" start="37096" end="37100" sStart="null" offset="133" sid="null" wn="1" wnkey="use%2:34:01::" text="Detergent laxatives (eg, docusate) at conventional doses are only stool softeners, and are rarely effective when used alone for patients at the end-of-life." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-684X-1-5.anc" start="46749" end="46753" sStart="null" offset="20" sid="r7.1.use.v.0436" wn="1" wnkey="use%2:34:01::" text="Benzodiazepines are used widely to treat terminal delirium as they are anxiolytics, amnestics, skeletal muscle relaxants, and antiepileptics [ 93 ] . Pre-dissolved oral lorazepam can be administered against the buccal mucosa and dose escalated to effect." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-684X-1-5.anc" start="2296" end="2301" sStart="null" offset="100" sid="r7.1.use.v.0324" wn="1" wnkey="use%2:34:01::" text="The central hypothesis is that a core curriculum designed, written and taught by physicians using state of the art clinical knowledge and education theory, can be effective in reaching a second tier of physicians by having the newly trained physicians return to their work settings and seek to engage and educate a growing number of their peers using and adapting the provided educational materials." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-684X-1-5.anc" start="37096" end="37100" sStart="null" offset="133" sid="null" wn="1" wnkey="use%2:34:01::" text="Detergent laxatives (eg, docusate) at conventional doses are only stool softeners, and are rarely effective when used alone for patients at the end-of-life." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-684X-1-5.anc" start="37757" end="37762" sStart="null" offset="0" sid="null" wn="2" wnkey="try_out%2:41:00::" text="This leads to the sense that &quot;nothing works&quot; when, in fact, nothing has been &lt;b&gt;tried&lt;/b&gt; to its maximal therapeutic dose." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-684X-1-5.anc" start="45313" end="45316" sStart="null" offset="0" sid="null" wn="1" wnkey="try%2:41:00::" text="It may be appropriate to evaluate and &lt;b&gt;try&lt;/b&gt; to reverse treatable contributing factors." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-684X-1-5.anc" start="37757" end="37762" sStart="null" offset="0" sid="null" wn="2" wnkey="try_out%2:41:00::" text="This leads to the sense that &quot;nothing works&quot; when, in fact, nothing has been &lt;b&gt;tried&lt;/b&gt; to its maximal therapeutic dose." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-684X-1-5.anc" start="37757" end="37762" sStart="null" offset="0" sid="null" wn="2" wnkey="try_out%2:41:00::" text="This leads to the sense that &quot;nothing works&quot; when, in fact, nothing has been &lt;b&gt;tried&lt;/b&gt; to its maximal therapeutic dose." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-684X-1-5.anc" start="37757" end="37762" sStart="null" offset="0" sid="null" wn="2" wnkey="try_out%2:41:00::" text="This leads to the sense that &quot;nothing works&quot; when, in fact, nothing has been &lt;b&gt;tried&lt;/b&gt; to its maximal therapeutic dose." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-684X-1-5.anc" start="37757" end="37762" sStart="null" offset="0" sid="null" wn="2" wnkey="try_out%2:41:00::" text="This leads to the sense that &quot;nothing works&quot; when, in fact, nothing has been &lt;b&gt;tried&lt;/b&gt; to its maximal therapeutic dose." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-684X-1-5.anc" start="37757" end="37762" sStart="null" offset="0" sid="null" wn="2" wnkey="try_out%2:41:00::" text="This leads to the sense that &quot;nothing works&quot; when, in fact, nothing has been &lt;b&gt;tried&lt;/b&gt; to its maximal therapeutic dose." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-684X-1-5.anc" start="37757" end="37762" sStart="null" offset="0" sid="null" wn="2" wnkey="try_out%2:41:00::" text="This leads to the sense that &quot;nothing works&quot; when, in fact, nothing has been &lt;b&gt;tried&lt;/b&gt; to its maximal therapeutic dose." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-684X-1-5.anc" start="37757" end="37762" sStart="null" offset="0" sid="null" wn="2" wnkey="try_out%2:41:00::" text="This leads to the sense that &quot;nothing works&quot; when, in fact, nothing has been &lt;b&gt;tried&lt;/b&gt; to its maximal therapeutic dose." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-684X-1-5.anc" start="45313" end="45316" sStart="null" offset="0" sid="null" wn="1" wnkey="try%2:41:00::" text="It may be appropriate to evaluate and &lt;b&gt;try&lt;/b&gt; to reverse treatable contributing factors." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-684X-1-5.anc" start="37757" end="37762" sStart="null" offset="0" sid="null" wn="2" wnkey="try_out%2:41:00::" text="This leads to the sense that &quot;nothing works&quot; when, in fact, nothing has been &lt;b&gt;tried&lt;/b&gt; to its maximal therapeutic dose." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-684X-1-5.anc" start="5582" end="5588" sStart="null" offset="119" sid="r11.strong.j.0194" wn="1" wnkey="strong%3:00:00::" text="Fear of loss of control and dignity, abandonment, being a burden, and physical suffering can be so strong that patients desire hastened death." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-684X-1-5.anc" start="11673" end="11679" sStart="null" offset="155" sid="r11.severe.j.0394" wn="1" wnkey="severe%5:00:00:intense:00" text="When initiating or titrating analgesics, it is not necessary to traverse each step of the model sequentially; a patient with severe pain (7-10/10 on a numerical or visual analogue scale - NAS or VAS) may need to have step 3 opioids from the outset." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-684X-1-5.anc" start="16191" end="16197" sStart="null" offset="21" sid="r11.severe.j.0395" wn="1" wnkey="severe%5:00:00:intense:00" text="If pain is severe or uncontrolled, an increase of 50% to 100% should be expected." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-684X-1-5.anc" start="16292" end="16298" sStart="null" offset="20" sid="r11.severe.j.0396" wn="1" wnkey="severe%5:00:00:intense:00" text="In fact, if pain is severe and uncontrolled after 1 or 2 doses (eg, crescendo pain), do not wait for 24 hours to pass before increasing the routine dose." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-684X-1-5.anc" start="41274" end="41279" sStart="null" offset="223" sid="r9.sense.n.0975" wn="1" wnkey="sense%1:09:05::" text="However, most experts feel that dehydration in the last hours of living does not cause distress and may stimulate the release of endorphins and anaesthetic compounds that promote the patient's sense of well being [ 81 82 83 ] . Low blood pressure or weak pulse is part of the dying process and not an indication of dehydration." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-684X-1-5.anc" start="27864" end="27869" sStart="null" offset="117" sid="r9.sense.n.0190" wn="1" wnkey="sense%1:09:05::" text="Nonpharmacological interventions may also contribute significantly to the patient's and family's sense of well-being, and their ability to cope." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-684X-1-5.anc" start="17554" end="17565" sStart="null" offset="68" sid="r11.recommend.v.0484" wn="1" wnkey="recommend%2:32:01::" text="Not all opioid analgesics that are commonly available are recommended for acute or chronic dosing." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-684X-1-5.anc" start="18175" end="18186" sStart="null" offset="124" sid="r11.recommend.v.0485" wn="1" wnkey="recommend%2:32:01::" text="The mixed opioid agonist-antagonists such as pentazocine, butorphanol, nalbuphine, and dezocine are not recommended as routine analgesics." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-684X-1-5.anc" start="18998" end="19009" sStart="null" offset="43" sid="r11.recommend.v.0096" wn="1" wnkey="recommend%2:32:01::" text="Intramuscular injections are not recommended." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-684X-1-5.anc" start="3212" end="3223" sStart="null" offset="110" sid="r11.recommend.v.0483" wn="1" wnkey="recommend%2:32:01::" text="Two Advisory Boards of 24 expert physicians in ethics, hospice, and palliative care initially recommended the curricular content and format." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-684X-1-5.anc" start="18998" end="19009" sStart="null" offset="43" sid="r11.recommend.v.0096" wn="1" wnkey="recommend%2:32:01::" text="Intramuscular injections are not recommended." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-684X-1-5.anc" start="36679" end="36683" sStart="null" offset="103" sid="r7.poor.j.0929" wn="4" wnkey="poor%3:00:02::" text="Cathartic medications fall into several classes [ 70 ] . For patients with advanced illness, poor mobility, and decreased oral intake, a stimulant laxative (eg, prune juice, senna, casanthranol, or bisacodyl) is appropriate front-line therapy [ 71 ] . Osmotic laxatives (eg, magnesium salts, lactulose, sorbitol) may be added." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-684X-1-5.anc" start="36679" end="36683" sStart="null" offset="103" sid="r7.poor.j.0929" wn="4" wnkey="poor%3:00:02::" text="Cathartic medications fall into several classes [ 70 ] . For patients with advanced illness, poor mobility, and decreased oral intake, a stimulant laxative (eg, prune juice, senna, casanthranol, or bisacodyl) is appropriate front-line therapy [ 71 ] . Osmotic laxatives (eg, magnesium salts, lactulose, sorbitol) may be added." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-684X-1-5.anc" start="37648" end="37658" sStart="null" offset="63" sid="r10.particular.j.0383" wn="2" wnkey="particular%5:00:02:specific:00" text="A frequent mistake is the failure to dose-escalate a particular cathartic." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-684X-1-5.anc" start="21106" end="21110" sStart="null" offset="0" sid="null" wn="1" wnkey="part%1:24:00::" text="It is a prevalent myth that the administration of opioid analgesics for pain management causes addiction [ 27 ] . Confusion about the differences between addiction, tolerance, and physical dependence is in &lt;b&gt;part&lt;/b&gt; responsible." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-684X-1-5.anc" start="21106" end="21110" sStart="null" offset="0" sid="null" wn="2147483647" wnkey="null" text="It is a prevalent myth that the administration of opioid analgesics for pain management causes addiction [ 27 ] . Confusion about the differences between addiction, tolerance, and physical dependence is in &lt;b&gt;part&lt;/b&gt; responsible." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-684X-1-5.anc" start="21106" end="21110" sStart="null" offset="0" sid="null" wn="1" wnkey="part%1:24:00::" text="It is a prevalent myth that the administration of opioid analgesics for pain management causes addiction [ 27 ] . Confusion about the differences between addiction, tolerance, and physical dependence is in &lt;b&gt;part&lt;/b&gt; responsible." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-684X-1-5.anc" start="2559" end="2565" sStart="null" offset="363" sid="r8.number.n.0787" wn="1" wnkey="number%1:07:00::" text="The central hypothesis is that a core curriculum designed, written and taught by physicians using state of the art clinical knowledge and education theory, can be effective in reaching a second tier of physicians by having the newly trained physicians return to their work settings and seek to engage and educate a growing number of their peers using and adapting the provided educational materials." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-684X-1-5.anc" start="35441" end="35447" sStart="null" offset="120" sid="r9.normal.j.0787" wn="3" wnkey="normal%3:00:03::" text="As there is a wide range of &quot;normal&quot; in bowel habits, begin by assessing what the patient considers normal bowel function." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-684X-1-5.anc" start="6251" end="6255" sStart="null" offset="0" sid="null" wn="1" wnkey="lose%2:40:02::" text="Unresolved relationships or financial, legal, or practical matters may be sources of distress [ 10 ] . Because 30% of families spend their life savings and/or &lt;b&gt;lose&lt;/b&gt; a source of income in order to care for the patient, it is important to know about financial status and health insurance coverage [ 11 ] . The need for practical help must be addressed; even the best of care plans may fail if the chores of day-to-day living are not attended to [ 12 ] ." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1472-684X-1-5.anc" start="13087" end="13091" sStart="null" offset="0" sid="null" wn="1" wnkey="long%3:00:02::" text="Extended-release NSAIDs, or those with &lt;b&gt;long&lt;/b&gt; half-lives (eg, piroxicam), are likely to enhance adherence." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-684X-1-5.anc" start="409" end="413" sStart="null" offset="108" sid="r8.life.n.0921" wn="4" wnkey="life%1:26:00::" text="Many of the approaches will apply much earlier in the course of the illness, not just at the end of life." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-684X-1-5.anc" start="6666" end="6670" sStart="null" offset="63" sid="r8.life.n.0798" wn="3 2" wnkey="null" text="Every person has a spiritual dimension to his or her life." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-684X-1-5.anc" start="10530" end="10534" sStart="null" offset="280" sid="r8.life.n.0651" wn="1" wnkey="life%1:26:01::" text="Frequently, pharmacological and non-pharmacological interventions and an interdisciplinary plan that includes other health care professionals (nurses, social workers, pharmacists, chaplains, physiotherapists, occupational therapists, child life specialists, etc) are required to manage pain effectively." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1472-684X-1-5.anc" start="31637" end="31642" sStart="null" offset="0" sid="null" wn="1" wnkey="know%2:31:01::" text="Dopamine-mediated nausea is probably the most frequently targeted for initial symptom management, even when the precise mechanism of nausea is not &lt;b&gt;known&lt;/b&gt;." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1472-684X-1-5.anc" start="31637" end="31642" sStart="null" offset="0" sid="null" wn="1" wnkey="know%2:31:01::" text="Dopamine-mediated nausea is probably the most frequently targeted for initial symptom management, even when the precise mechanism of nausea is not &lt;b&gt;known&lt;/b&gt;." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-684X-1-5.anc" start="36773" end="36778" sStart="null" offset="0" sid="null" wn="1" wnkey="juice%1:13:00::" text="Cathartic medications fall into several classes [ 70 ] . For patients with advanced illness, poor mobility, and decreased oral intake, a stimulant laxative (eg, prune &lt;b&gt;juice&lt;/b&gt;, senna, casanthranol, or bisacodyl) is appropriate front-line therapy [ 71 ] . Osmotic laxatives (eg, magnesium salts, lactulose, sorbitol) may be added." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-684X-1-5.anc" start="36773" end="36778" sStart="null" offset="0" sid="null" wn="1" wnkey="juice%1:13:00::" text="Cathartic medications fall into several classes [ 70 ] . For patients with advanced illness, poor mobility, and decreased oral intake, a stimulant laxative (eg, prune &lt;b&gt;juice&lt;/b&gt;, senna, casanthranol, or bisacodyl) is appropriate front-line therapy [ 71 ] . Osmotic laxatives (eg, magnesium salts, lactulose, sorbitol) may be added." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-684X-1-5.anc" start="36773" end="36778" sStart="null" offset="0" sid="null" wn="1" wnkey="juice%1:13:00::" text="Cathartic medications fall into several classes [ 70 ] . For patients with advanced illness, poor mobility, and decreased oral intake, a stimulant laxative (eg, prune &lt;b&gt;juice&lt;/b&gt;, senna, casanthranol, or bisacodyl) is appropriate front-line therapy [ 71 ] . Osmotic laxatives (eg, magnesium salts, lactulose, sorbitol) may be added." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-684X-1-5.anc" start="36773" end="36778" sStart="null" offset="0" sid="null" wn="1" wnkey="juice%1:13:00::" text="Cathartic medications fall into several classes [ 70 ] . For patients with advanced illness, poor mobility, and decreased oral intake, a stimulant laxative (eg, prune &lt;b&gt;juice&lt;/b&gt;, senna, casanthranol, or bisacodyl) is appropriate front-line therapy [ 71 ] . Osmotic laxatives (eg, magnesium salts, lactulose, sorbitol) may be added." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-684X-1-5.anc" start="36773" end="36778" sStart="null" offset="0" sid="null" wn="1" wnkey="juice%1:13:00::" text="Cathartic medications fall into several classes [ 70 ] . For patients with advanced illness, poor mobility, and decreased oral intake, a stimulant laxative (eg, prune &lt;b&gt;juice&lt;/b&gt;, senna, casanthranol, or bisacodyl) is appropriate front-line therapy [ 71 ] . Osmotic laxatives (eg, magnesium salts, lactulose, sorbitol) may be added." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-684X-1-5.anc" start="36773" end="36778" sStart="null" offset="0" sid="null" wn="1" wnkey="juice%1:13:00::" text="Cathartic medications fall into several classes [ 70 ] . For patients with advanced illness, poor mobility, and decreased oral intake, a stimulant laxative (eg, prune &lt;b&gt;juice&lt;/b&gt;, senna, casanthranol, or bisacodyl) is appropriate front-line therapy [ 71 ] . Osmotic laxatives (eg, magnesium salts, lactulose, sorbitol) may be added." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-684X-1-5.anc" start="36773" end="36778" sStart="null" offset="0" sid="null" wn="1" wnkey="juice%1:13:00::" text="Cathartic medications fall into several classes [ 70 ] . For patients with advanced illness, poor mobility, and decreased oral intake, a stimulant laxative (eg, prune &lt;b&gt;juice&lt;/b&gt;, senna, casanthranol, or bisacodyl) is appropriate front-line therapy [ 71 ] . Osmotic laxatives (eg, magnesium salts, lactulose, sorbitol) may be added." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-684X-1-5.anc" start="36773" end="36778" sStart="null" offset="0" sid="null" wn="1" wnkey="juice%1:13:00::" text="Cathartic medications fall into several classes [ 70 ] . For patients with advanced illness, poor mobility, and decreased oral intake, a stimulant laxative (eg, prune &lt;b&gt;juice&lt;/b&gt;, senna, casanthranol, or bisacodyl) is appropriate front-line therapy [ 71 ] . Osmotic laxatives (eg, magnesium salts, lactulose, sorbitol) may be added." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-684X-1-5.anc" start="36773" end="36778" sStart="null" offset="0" sid="null" wn="1" wnkey="juice%1:13:00::" text="Cathartic medications fall into several classes [ 70 ] . For patients with advanced illness, poor mobility, and decreased oral intake, a stimulant laxative (eg, prune &lt;b&gt;juice&lt;/b&gt;, senna, casanthranol, or bisacodyl) is appropriate front-line therapy [ 71 ] . Osmotic laxatives (eg, magnesium salts, lactulose, sorbitol) may be added." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-684X-1-5.anc" start="38581" end="38585" sStart="null" offset="19" sid="r10.help.v.0979" wn="1" wnkey="help%2:41:00::" text="They can help decrease the pressure from family or others exhorting the patient to be more alert, energetic, and conversant." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-684X-1-5.anc" start="7163" end="7167" sStart="null" offset="16" sid="r9.full.j.0682" wn="2" wnkey="full%5:00:01:whole:00" text="Equipped with a full assessment of the nature and context of the issues that are causing suffering for the patient and family, the physician can then address each issue in turn." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-684X-1-5.anc" start="45733" end="45739" sStart="null" offset="174" sid="r8.family.n.0993" wn="2" wnkey="family%1:14:00::" text="Management appropriately focuses on the management of the symptoms associated with the terminal delirium in order to settle the patient and the family [ 89 ] ." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-684X-1-5.anc" start="26373" end="26379" sStart="null" offset="25" sid="r8.family.n.0673" wn="2" wnkey="family%1:14:00::" text="Concerns about finances, family conflicts, future disability, dependency, and existential concerns will not resolve with medication." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-684X-1-5.anc" start="38462" end="38470" sStart="null" offset="77" sid="r8.family.n.0674" wn="1 2" wnkey="null" text="Physicians can play an instrumental role by educating patients and families about the nature of the symptom, and by giving the patient &quot;permission&quot; to rest." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-684X-1-5.anc" start="4094" end="4100" sStart="null" offset="158" sid="r8.family.n.0128" wn="2" wnkey="family%1:14:00::" text="Management strategies to relieve suffering in end-of-life care begin with a comprehensive assessment of the whole patient, and his or her family." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-684X-1-5.anc" start="27306" end="27314" sStart="null" offset="83" sid="r8.family.n.0907" wn="1" wnkey="family%1:14:02::" text="Breathlessness may be one of the most distressing symptoms for patients, families, and caregivers." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-684X-1-5.anc" start="24748" end="24754" sStart="null" offset="141" sid="r8.family.n.0631" wn="1" wnkey="family%1:14:02::" text="Other members of the health care team can provide invaluable assistance to support the depressed patient, and his or her family." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-684X-1-5.anc" start="4167" end="4175" sStart="null" offset="0" sid="null" wn="2" wnkey="familiar%3:00:02::" text="This approach to assessment may be quite distinct from &lt;b&gt;familiar&lt;/b&gt; history taking and physical examination techniques." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-684X-1-5.anc" start="28872" end="28876" sStart="null" offset="179" sid="r7.1.face.n.0047" wn="1" wnkey="human_face%1:08:01::" text="This may have a placebo effect [ 47 ] . In addition, its effectiveness may be explained by the observation that cool air moving across the patient's face (eg, from compressed air by nasal prongs, or from a fan) may provide equal relief due to the stimulation of the V2 branch of the fifth cranial nerve [ 48 ] ." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-684X-1-5.anc" start="29534" end="29542" sStart="null" offset="0" sid="null" wn="1" wnkey="physical_exercise%1:04:00::" text="In some patients, subjective relief may also be associated with a measurable increase in &lt;b&gt;exercise&lt;/b&gt; tolerance and mobility [ 50 51 ] ." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-684X-1-5.anc" start="29534" end="29542" sStart="null" offset="0" sid="null" wn="1" wnkey="physical_exercise%1:04:00::" text="In some patients, subjective relief may also be associated with a measurable increase in &lt;b&gt;exercise&lt;/b&gt; tolerance and mobility [ 50 51 ] ." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-684X-1-5.anc" start="29534" end="29542" sStart="null" offset="0" sid="null" wn="1" wnkey="physical_exercise%1:04:00::" text="In some patients, subjective relief may also be associated with a measurable increase in &lt;b&gt;exercise&lt;/b&gt; tolerance and mobility [ 50 51 ] ." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-684X-1-5.anc" start="29534" end="29542" sStart="null" offset="0" sid="null" wn="1" wnkey="physical_exercise%1:04:00::" text="In some patients, subjective relief may also be associated with a measurable increase in &lt;b&gt;exercise&lt;/b&gt; tolerance and mobility [ 50 51 ] ." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-684X-1-5.anc" start="1657" end="1669" sStart="null" offset="39" sid="r1.development.n.0083" wn="" wnkey="null" text="To increase physician knowledge of new developments in palliation and their level of clinical competence in end-of-life care, the Institute for Ethics at the American Medical Association, with support from the Robert Wood Johnson Foundation, embarked on the Education for Physicians on End-of-life Care (EPEC) Project." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-684X-1-5.anc" start="1657" end="1669" sStart="null" offset="39" sid="r1.development.n.0083" wn="4" wnkey="development%1:11:01::" text="To increase physician knowledge of new developments in palliation and their level of clinical competence in end-of-life care, the Institute for Ethics at the American Medical Association, with support from the Robert Wood Johnson Foundation, embarked on the Education for Physicians on End-of-life Care (EPEC) Project." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-684X-1-5.anc" start="1657" end="1669" sStart="null" offset="39" sid="r1.development.n.0083" wn="4" wnkey="development%1:11:01::" text="To increase physician knowledge of new developments in palliation and their level of clinical competence in end-of-life care, the Institute for Ethics at the American Medical Association, with support from the Robert Wood Johnson Foundation, embarked on the Education for Physicians on End-of-life Care (EPEC) Project." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-684X-1-5.anc" start="18539" end="18546" sStart="null" offset="27" sid="r10.control.n.0619" wn="3" wnkey="control%1:04:02::" text="If patients have good pain control on stable doses of an opioid, and are not experiencing adverse effects (especially drowsiness), it is safe to drive a car." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-684X-1-5.anc" start="49134" end="49140" sStart="null" offset="32" sid="r10.common.j.0529" wn="4" wnkey="common%5:00:00:familiar:02" text="A host of physical symptoms are common in patients with advanced life-threatening illness." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-684X-1-5.anc" start="19760" end="19766" sStart="null" offset="13" sid="r10.common.j.0480" wn="2" wnkey="common%3:00:01::" text="Opioids have common and uncommon adverse effects (Table 3)." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-684X-1-5.anc" start="9253" end="9264" sStart="null" offset="194" sid="r11.combination.n.0349" wn="1" wnkey="combination%1:14:00::" text="Although neuropathic pain may respond well to opioids, adjuvant analgesics (tricyclic antidepressants, anticonvulsants, antiarrhythmics, etc) are often required in combination with opioids to achieve adequate relief." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-684X-1-5.anc" start="26287" end="26298" sStart="null" offset="70" sid="r11.combination.n.0281" wn="1" wnkey="combination%1:14:00::" text="Like depression, the management of anxiety often requires a combination of supportive therapy and medications." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-684X-1-5.anc" start="3123" end="3129" sStart="null" offset="21" sid="r10.board.n.0649" wn="1" wnkey="board%1:14:00::" text="Two Advisory Boards of 24 expert physicians in ethics, hospice, and palliative care initially recommended the curricular content and format." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-684X-1-5.anc" start="27585" end="27592" sStart="null" offset="167" sid="r11.benefit.n.0896" wn="2" wnkey="benefit%1:07:00::" text="Where possible, the underlying cause should be treated to at least provide symptomatic relief when the burden of the therapy does not outweigh the benefit." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-684X-1-5.anc" start="40476" end="40482" sStart="null" offset="0" sid="null" wn="1" wnkey="become%2:30:00::" text="Joints may &lt;b&gt;become&lt;/b&gt; uncomfortable if they are not moved [ 77 ] . Continuous pressure on the same area of skin, particularly over bony prominences, will increase the risk of skin ischemia, and pain [ 78 ] . As the patient approaches death, provide adequate support and cushioning on the bed to lessen the need for uncomfortable turning." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-684X-1-5.anc" start="36946" end="36951" sStart="null" offset="0" sid="null" wn="1" wnkey="add%2:30:00::" text="Cathartic medications fall into several classes [ 70 ] . For patients with advanced illness, poor mobility, and decreased oral intake, a stimulant laxative (eg, prune juice, senna, casanthranol, or bisacodyl) is appropriate front-line therapy [ 71 ] . Osmotic laxatives (eg, magnesium salts, lactulose, sorbitol) may be &lt;b&gt;added&lt;/b&gt;." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-684X-1-5.anc" start="36946" end="36951" sStart="null" offset="0" sid="null" wn="" wnkey="null" text="Cathartic medications fall into several classes [ 70 ] . For patients with advanced illness, poor mobility, and decreased oral intake, a stimulant laxative (eg, prune juice, senna, casanthranol, or bisacodyl) is appropriate front-line therapy [ 71 ] . Osmotic laxatives (eg, magnesium salts, lactulose, sorbitol) may be &lt;b&gt;added&lt;/b&gt;." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-684X-1-5.anc" start="36946" end="36951" sStart="null" offset="0" sid="null" wn="1" wnkey="add%2:30:00::" text="Cathartic medications fall into several classes [ 70 ] . For patients with advanced illness, poor mobility, and decreased oral intake, a stimulant laxative (eg, prune juice, senna, casanthranol, or bisacodyl) is appropriate front-line therapy [ 71 ] . Osmotic laxatives (eg, magnesium salts, lactulose, sorbitol) may be &lt;b&gt;added&lt;/b&gt;." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-684X-1-5.anc" start="36946" end="36951" sStart="null" offset="0" sid="null" wn="1" wnkey="add%2:30:00::" text="Cathartic medications fall into several classes [ 70 ] . For patients with advanced illness, poor mobility, and decreased oral intake, a stimulant laxative (eg, prune juice, senna, casanthranol, or bisacodyl) is appropriate front-line therapy [ 71 ] . Osmotic laxatives (eg, magnesium salts, lactulose, sorbitol) may be &lt;b&gt;added&lt;/b&gt;." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-684X-1-5.anc" start="46346" end="46349" sStart="null" offset="0" sid="null" wn="1" wnkey="add%2:30:00::" text="While a trial of opioids may be beneficial in the unconscious patient who is difficult to assess, physicians must remember that opioids may accumulate and &lt;b&gt;add&lt;/b&gt; to delirium when renal clearance is poor [ 91 92 ] . If the trial of increased opioids does not relieve the agitation, or makes the delirium worse by increasing agitation or precipitating myoclonic jerks or seizures (rare), then pursue alternate therapies directed at suppressing the symptoms associated with delirium." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-684X-1-5.anc" start="36946" end="36951" sStart="null" offset="0" sid="null" wn="1" wnkey="add%2:30:00::" text="Cathartic medications fall into several classes [ 70 ] . For patients with advanced illness, poor mobility, and decreased oral intake, a stimulant laxative (eg, prune juice, senna, casanthranol, or bisacodyl) is appropriate front-line therapy [ 71 ] . Osmotic laxatives (eg, magnesium salts, lactulose, sorbitol) may be &lt;b&gt;added&lt;/b&gt;." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-684X-1-5.anc" start="36946" end="36951" sStart="null" offset="0" sid="null" wn="1" wnkey="add%2:30:00::" text="Cathartic medications fall into several classes [ 70 ] . For patients with advanced illness, poor mobility, and decreased oral intake, a stimulant laxative (eg, prune juice, senna, casanthranol, or bisacodyl) is appropriate front-line therapy [ 71 ] . Osmotic laxatives (eg, magnesium salts, lactulose, sorbitol) may be &lt;b&gt;added&lt;/b&gt;." />
  </sentences>
</list>